Abstract 1221: Imaging mass cytometry of pelareorep treated early breast cancer samples reveals developing tertiary lymphoid structures.
Julian Olea(University of Southern California), Kevin R. Kelly(Keck Hospital of USC), Kaijin Wu(University of Southern California), Han Wu(Second Military Medical University), P Zaránd, Claudia Villa Celi(University of Southern California), Steffan T. Nawrocki(University of Arizona), Homa Dadrastoussi(University of Southern California), Xuelian Chen(Jiangsu University), Richard Trauger(Oncolytics Biotech (Canada)), Thomas C. Heineman(Oncolytics Biotech (Canada)), Jennifer S. Carew(University of Arizona)
Cited by 0
Related Papers
Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
|Clinical Cancer Research|2008|782
Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy
|Cancer Letters|2008|426
Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
|Clinical Cancer Research|2015|355